JOSEPH M. MAHADY
Profile
First Name
: JOSEPH
Middle Name
: M.
Last Name
: MAHADY
Related Companies
Titles
Company Name
Related People
DIRECTOR
RUSSELL CLAYTON, D.O., KATHRYN COLE, JOHN C. COOPER, JOHN G. COOPER, GEORGE COX, CRAIG FRASER, CRAIG E. FRASER, DANIEL GEFFKEN, THOMAS C. HOY, JAMES HUANG, JOHN LEONE, JOHN R. LEONE, MICHAEL L. MAGEE, JOSEPH MAHADY, THOMAS F. MILLER, PH.D., MBA, BRUCE PEACOCK, BRUCE A. PEACOCK, MARVIN E. ROSENTHALE, MARVIN E. ROSENTHALE, PH.D., BRIAN SCHREIBER, STEVEN SIMONSON, STEVEN A. SIMONSON, JOHN TATTORY, JOHN A. TATTORY, MARY B. TEMPLETON, MARY B. TEMPLETON, ESQ., LAWRENCE A. WEINSTEIN
DIRECTOR
FREDRIC COHEN, A. BRIAN DAVIS, A. BRIAN DAVIS, BRIAN DAVIS, ERNEST EICHENBERG III, JOHN JOHNSON, JOHN H. JOHNSON, ESPEN TIDEMANN JORGENSEN, RICHARD KOLLENDER, GARHENG KONG, ALEXANDER LINDSTROM, STEPHEN LONG, STEVE LONG, ROBERT LUTZ, MATTHEW PAULS, H. JOSEPH REISER, JEFFREY W. SHERMAN, EIGIL STRAY SPETALEN, MARTEN STEEN, HILDE H. STEINEGER, RUTH THIEROFF-EKERDT
DIRECTOR
RUSSELL CLAYTON, D.O., KATHRYN COLE, JOHN C. COOPER, JOHN G. COOPER, GEORGE COX, CRAIG FRASER, CRAIG E. FRASER, DANIEL GEFFKEN, THOMAS C. HOY, JAMES HUANG, JOHN LEONE, JOHN R. LEONE, MICHAEL L. MAGEE, JOSEPH MAHADY, THOMAS F. MILLER, PH.D., MBA, BRUCE PEACOCK, BRUCE A. PEACOCK, MARVIN E. ROSENTHALE, MARVIN E. ROSENTHALE, PH.D., BRIAN SCHREIBER, STEVEN SIMONSON, STEVEN A. SIMONSON, JOHN TATTORY, JOHN A. TATTORY, MARY B. TEMPLETON, MARY B. TEMPLETON, ESQ., LAWRENCE A. WEINSTEIN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2018-12-21
D/A
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2018-03-30
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
2018-07-02
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2018-03-30
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2017-10-27
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2017-02-13
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-06-29
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1 - $1,000,000
2014-10-10
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1 - $1,000,000
2013-12-03
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
NO REVENUES
Equity
2013-08-31
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
NO REVENUES
Equity
2013-05-24
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
NO REVENUES
Equity
2013-02-28
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
NO REVENUES
2013-02-13
